A novel method for detecting the concentration of a metabolite in a fluid sample is provided. Devices for the detection of the analyte are also provided. In particular, a device for determining the concentration of 11-dehydro thromboxane in a urine sample and comparing it to a set of standardized quartile concentrations is provided. A concentration of urinary 11-dehydro thromboxane that falls within the fourth quartile is indicative of a greatly increased risk of a recurrent cardiovascular event.

 
Web www.patentalert.com

< Nitric oxide donating diuretic compounds, compositions and methods of use

> Mitotic kinesin inhibitors

> Analogues of lipid mediators derived from .omega.-3 PUFAs and methods of use

~ 00547